Rehabilitation techniques in ankylosing spondylitis management: a case report

Henderson, Shawn
September 2003
Journal of the Canadian Chiropractic Association;Sep2003, Vol. 47 Issue 3, p161
Academic Journal
Ankylosing spondylitis (AS) is a chronic inflammatory disorder of the musculoskeletal system. Progressive complaints of axial stiffness and restriction in movement may not be addressed by general medical practitioners. While AS has a progressive natural history, chiropractors may play a significant role in early detection, patient education, and management. Early diagnosis and therapy may help to minimize future pain and disability. Chiropractic treatment methods coupled with individualized active rehabilitation techniques should be directed to reduce pain, minimize functional loss and optimize quality of life.


Related Articles

  • Section of Rheumatology & Rehabilitation: short papers. Golding, D. N. // Journal of the Royal Society of Medicine;Nov1984, Vol. 77 Issue 11, p978 

    The article provides information on papers discussed at a meeting of the Section of Rheumatology and Rehabilitation of the Royal Society of Medicine held in Great Britain in 1984. The forum opened with a paper on primary multifocal fibrositis and chronic benzodiazepine. Doctor T. D. Kennedy...

  • Chiropractic and Ankylosing Spondylitis. Burkhart, Lori A. // ACA News (American Chiropractic Association);Jun/Jul2015, Vol. 11 Issue 5, p24 

    The article focuses on the significance of chiropractic in the diagnosis and management of akylosing spondylitis (AS), a form of arthritis primarily affecting the spine. Topics include the problems associated with the diagnosis of AS, the relief provided by chiropractic manipulation to patients...

  • Mobility spectacles for ankylosing spondylitis. Kelly, S.P.; Storey, J.K. // BMJ: British Medical Journal (International Edition);6/24/89, Vol. 298 Issue 6689, p1704 

    Focuses on the development of prismatic spectacles for patient with ankylosing spondylitis. Assessment of chromatic aberrations of the prisms; Modification of optical aids; Recommendation of the device to general practitioners.

  • Corrigendum.  // Rheumatology;Jul2010, Vol. 49 Issue 7, p1423 

    A correction to the article "Short-Term Efficacy of Combination Methotrexate and Infliximab in Patients With Ankylosing Spondylitis: A Clinical and Magnetic Resonance Imaging Correlation," by E. K. Li and colleagues, published in the 2008 issue, is presented.

  • Empfehlungen für die Behandlung der ankylosierenden Spondylitis gemäß ASAS/EULAR. Kiltz, U.; Sieper, J.; Braun, J. // Zeitschrift für Rheumatologie;Feb2013, Vol. 72 Issue 1, p71 

    The ASAS/EULAR recommendations for the management of ankylosing spondylitis have been updated in 2010. The recommendations have been extended from 10 to 11 recommendations and 4 superior principles have been introduced based on the level of evidence and expert knowledge. The recommendations have...

  • Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Dougados, Maxime; Boumier, Patrick; Amor, Bernard // British Medical Journal (Clinical Research Edition);10/11/1986, Vol. 293 Issue 6552, p911 

    Examines the efficacy of sulphasalazine in ankylosing spondylitis with peripheral arthritis. Incrimination of the intestinal microbial infection in the pathogenesis of active exacerbations; Diagnosis of ankylosing spondylitis; Criteria used to asses the efficacy of the treatment.

  • New indication OK'd for etanercept.  // Drug Topics;8/04/2003, Vol. 147 Issue 15, p6 

    Reports on the U.S. Food & Drug Administration's approval of the biologic Etanercept for the reduction of signs and symptoms in patients with active ankylosing spondylitis.

  • Etanercept.  // Reactions Weekly;9/4/2010, Issue 1317, p23 

    The article describes the case of a man who developed scurvy as initial symptom of Whipple's disease while receiving treatment with etanercept due to ankylosing spondylitis.

  • Adalimumab.  // Reactions Weekly;5/5/2012, Issue 1400, p6 

    The article describes the case of a 35-year-old man who developed infertility after receiving subcutaneous adalimumab for ankylosing spondylitis (AS).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics